Inhibition of FASN significantly enhances the radiosensitivity of glioblastoma cells, and combining FASN blockade with focal radiation therapy prolongs the survival of glioblastoma-tumor-bearing mice [24]. This evidence concerns the gene FASN and glioblastoma.